Kamila A. Alexander, PhD, MPH, RN Helena A. Addison, BA Breanna N. - - PowerPoint PPT Presentation

kamila a alexander phd mph rn helena a addison ba breanna
SMART_READER_LITE
LIVE PREVIEW

Kamila A. Alexander, PhD, MPH, RN Helena A. Addison, BA Breanna N. - - PowerPoint PPT Presentation

Kamila A. Alexander, PhD, MPH, RN Helena A. Addison, BA Breanna N. Beard, BA Johns Hopkins School of Nursing PrEP for Women Conference September 25, 2018 BACK CKGR GROUND OUND 1 in 3 women CDC, 2017; NISVS, 2015; Interagency Federal


slide-1
SLIDE 1

Kamila A. Alexander, PhD, MPH, RN Helena A. Addison, BA Breanna N. Beard, BA Johns Hopkins School of Nursing PrEP for Women Conference September 25, 2018

slide-2
SLIDE 2

BACK CKGR GROUND OUND

1 in 3 women

CDC, 2017; NISVS, 2015; Interagency Federal Working Group Report, 2013

slide-3
SLIDE 3

– Health disparities disproportionately affect Black, Latina, and low-income women – Increase risks for HIV (and unintended pregnancies)

  • Condom negotiation
  • STI diagnoses/exposures
  • Partner HIV status unknown

– Women in abusive relationships express interest in risk reduction and prevention options – Need to determine safest ways to deliver PrEP (and contraceptives) to this population

Intima Intimate P te Par artner tner V Violence (I iolence (IPV) PV) and and Repr eproductiv

  • ductive

e Coer Coercion cion (R (RC) C)

Campbell, Lucea, Stockman & Draughon, 2012; Willie, et al, 2017; Garfinkel, et al, 2017

4x higher risk of HIV

slide-4
SLIDE 4

FRA FRACTURE CTURED D SY SYST STEM EMS

  • Barriers to healthcare IPV screening

and counseling

– Time – Poor or non-existent policies – Limited incentives for screening – Discomfort – Inadequate cross-sector collaborations with survivor advocate services

Colarossi et al, 2010; Jaffee et al, 2005; Yonaka, et al, 2007; Cha, et al, 2014; Tower, et al, 2006; Weeks, et al, 2008; Minsky-Kelly, et al.,

  • 2005. O’Campo, et al, 2011; Frankel, 2007.

CDC guidelines for PrEP use among women apply to a majority of women experiencing IPV.

slide-5
SLIDE 5

Multi-sector Collaboration to increase Contraceptive use and PrEP uptake among IPV-exposed women

IPV Service Providers Women’s Health Providers PrEP Providers

MULTI-SECTOR COLLABORATIONS

slide-6
SLIDE 6

TW TWO-PHASE STUD PHASE STUDY

Phase 1: Interviews & surveys with service providers from multiple health sectors –Reproductive health providers –PrEP providers –IPV service providers Phase 2: Survey of 100 women exposed to IPV and RC

slide-7
SLIDE 7

IPV LARC PrEP

Study Objective To understand the factors related to LARC and PrEP acceptability among IPV-exposed women

slide-8
SLIDE 8

METHODS

  • Convenience sample

– Women who have experienced a form of IPV within 12 months (Recruitment Goal: N = 100) – Recruitment at domestic violence service centers, youth development centers, beauty salons, etc. in the Baltimore area

  • Quantitative survey
  • Preliminary analysis procedure

– Descriptive statistics

slide-9
SLIDE 9

Yes 33% No 67%

PRE PRELIMIN LIMINAR ARY Y FINDING FINDINGS: S: PrE PrEP KNOWLEDG WLEDGE

slide-10
SLIDE 10

2 4 6 8 10 12 GENERAL COMMUNITY HEALTH CARE CENTER, VAN, OR CLINIC HOSPITAL REPRODUCTIVE HEALTH CARE CENTER (EX. PLANNED PARENTHOOD) PRIVATE MEDICAL PRACTICE HIV CLINIC DOMESTIC VIOLENCE ORGANIZATION

WHERE WOULD IPV-EXPOSED WOMEN PREFER TO GET PrEP?

LOCA CATIO TION FOR FOR OBT BTAIN AININ ING PrE PrEP

slide-11
SLIDE 11

5 10 15 20 25 30 PRIMARY CARE PROVIDER REPRODUCTIVE HEALTH PROVIDER (EX. OB/GYN) HIV/INFECTIOUS DISEASE SPECIALIST DOMESTIC VIOLENCE ADVOCATE

WHO WOULD IPV-EXPOSED WOMEN PREFER TO GET PrEP FROM?

ROLE OLE OF PE OF PERSON RSON PR PROVID VIDIN ING G PrE PrEP

slide-12
SLIDE 12

63% 22% 15%

WHO SHOULD MEDICAL PROVIDER TELL ABOUT PrEP?

All patients should be told about PrEP Only high-risk patients should be told about PrEP No patients should be told about PrEP

Pr Preliminar eliminary y Find Findings ings

slide-13
SLIDE 13
  • f women

would be embarrassed to ask their doctor to give them PrEP

  • f women

would be more likely to take PrEP if a health care provider recommended it.

WOMAN 24% PROVIDER 17% NO PREFEREN CE 59%

WHO SHOULD START THE PrEP CONVERSATION?

Pr Prelimi elimina nary y Find Findings ings: Pr Provide vider I r Inte nterac actions tions

slide-14
SLIDE 14

ROLE OF DOMESTIC VIOLENCE ADVOCATES

Would be more likely to take PrEP if a domestic violence advocate recommended the pill. Would be embarrassed to ask a domestic violence advocate for PrEP

PREL PRELIMI IMINAR ARY Y FIND FINDIN INGS GS

slide-15
SLIDE 15

Partner Controlled PrEP Use PREL PRELIMI IMINAR ARY Y FIND FINDIN INGS: GS: PAR ARTNER B TNER BEHA EHAVIO VIOR

slide-16
SLIDE 16

PRE PRELIMIN LIMINAR ARY Y FINDING FINDINGS: S: PAR ARTNER TNER REA REACTIO CTIONS

Yes 23% No 77%

“WILL YOUR PARTNER TELL

YOU NOT TO TAKE PrEP?”

21% 79%

VERBAL ABUSE RISK

7% 93%

PHYSICAL ABUSE RISK

slide-17
SLIDE 17

10% YES 15% YES

90% No 85% No

PARTNER WOULD HAVE SEX WITH SOMEONE ELSE PARTNER WOULD THREATEN TO LEAVE

PREL PRELIMI IMINAR ARY Y FIND FINDIN INGS: GS: PAR ARTNER R TNER REA EACTIO CTIONS NS

slide-18
SLIDE 18

PREL PRELIMI IMINAR ARY Y FIND FINDIN INGS: GS: PrEP PrEP SABO SABOTAGE GE

slide-19
SLIDE 19

What We Need From You

1) Participate (if eligible) 2) Provide your contact information if you would like to learn more about participation 3) Refer women in your care who may be interested in participating

Surveys – 15 minutes Complete one today! http://bit.ly/prepforproviders $5 gift card as thank you Interviews – 1 hour Location & time that fits your schedule $10 gift card as thank you

ONGOING ONGOING DATA A CO COLLE LLECTION CTION

slide-20
SLIDE 20

Leading the way in education, research and practice – locally and globally.